Goodwin advised Tessera Therapeutics on the deal. Tessera Therapeutics announced its Series C financing, which totaled over $300 million. Tessera is a biotechnology company pioneering a...
You must be a Standard 1 Year member to access this content.
Goodwin advised Tessera Therapeutics on the deal. Tessera Therapeutics announced its collaboration with Serotiny to engineer programmable Gene Writer proteins. Under the terms of the agreement, Serotiny...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Tessera Therapeutics on the deal. Tessera Therapeutics, an early-stage life sciences company founded by Flagship Pioneering, announced today that it has raised...
You must be a Standard 1 Year member to access this content.
